Biblioteca Digital

971 resultados para Pharmaceutical Sciences

Does rosiglitazone increase cardiovascular outcomes?

Relevância:

60.00% 60.00%

Publicador:

Is fingolimod an advancement in the treatment of multiple sclerosis?

Relevância:

60.00% 60.00%

Publicador:

Rosiglitazone: rosy news for a thiazolidinedione

Relevância:

60.00% 60.00%

Publicador:

Ximelagatran - recent comparisons with warfarin

Relevância:

60.00% 60.00%

Publicador:

Calmodulin kinase II as a target for inhibition in cardiac disease

Relevância:

60.00% 60.00%

Publicador:

Recent evidence of sustained benefit with exenatide in Type 2 diabetes

Relevância:

60.00% 60.00%

Publicador:

BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia

Relevância:

60.00% 60.00%

Publicador:

Is exenatide advancing the treatment of Type 2 diabetes?

Relevância:

60.00% 60.00%

Publicador:

Bradykinin B2 receptors - a target in diabetic nephropathy

Relevância:

60.00% 60.00%

Publicador:

Pregabalin or morphine and gabapentin for neuropathic pain

Relevância:

60.00% 60.00%

Publicador:

Is AMN-107 a step forward from imatinib in the treatment of chronic myeloid leukaemia?

Relevância:

60.00% 60.00%

Publicador:

The effects of both noradrenaline and CGP12177, mediated through human Beta1-adrenoceptors, are reduced by PDE3 in human atrium but PDE4 in CHO cells

Relevância:

60.00% 60.00%

Publicador:

Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration

Relevância:

60.00% 60.00%

Publicador:

New drugs and new targets down under in 2006: highlights from the 3rd Australian Health and Medical Research Congress

Relevância:

60.00% 60.00%

Publicador:

Rho-kinase inhibitors show promise in pulmonary hypertension

Relevância:

60.00% 60.00%

Publicador:

«
1
2
...
4
5
6
7
8
9
10
...
64
65
»